Stock Trading History of Bryson Vaughn D

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Bryson Vaughn D since year 2005. The trader's CIK number is 1189539. At the time of this reporting, Bryson Vaughn D is the Director of Atherogenics Inc (stock ticker symbol AGIX).
Note that in the past BRYSON VAUGHN D also reported insider trading activities as an insider of the following companies:

Insider Activities at Atherogenics Inc (AGIX)
Insider Activities at Amylin Pharmaceuticals Inc (AMLN)
Insider Activities at Icos Corp / De (ICOS)

Stock purchases, sales, and option exercises reported by insider *Bryson Vaughn D* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2008-01-22	AGIX	Atherogenics Inc	Sale	3,386	.39	1,320
2008-02-08	AGIX	Atherogenics Inc	Purchase	50,000	.64	32,000
2007-12-27	AGIX	Atherogenics Inc	Sale	48,732	.40	19,492
2007-12-28	AGIX	Atherogenics Inc	Sale	24,733	.38	9,464
2007-12-26	AGIX	Atherogenics Inc	Sale	2,440	.40	976
2007-12-20	AGIX	Atherogenics Inc	Sale	7,657	.43	3,292
2007-08-29	AGIX	Atherogenics Inc	Sale	55,518	2.15	119,363
2006-06-29	AGIX	Atherogenics Inc	Purchase	22,868	12.97	296,659
2006-06-30	AGIX	Atherogenics Inc	Purchase	17,132	13.06	223,793
2006-05-30	AGIX	Atherogenics Inc	Purchase	20,000	13.87	277,474
2005-05-06	AMLN	Amylin Pharmaceuticals Inc	Purchase	20,000	16.72	334,300
2005-03-31	ICOS	Icos Corp / De	Purchase	5,000	22.54	112,705

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Bryson Vaughn D (Director of Atherogenics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.